Centogene N.V.
Centogene N.V. (CNTG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CNTG · as of Jun 9, 2026
Key Statistics
Explore Centogene N.V. Data
cntg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The CNTG analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $2.50, representing +669.23% upside from the current price of $0.33.
Competitors & Peers
cntg competitorsCNTG
APGN
CHRO
CJJD
EPIX
ETAOFStock Performance
Full HistoryAbout Centogene N.V.
Centogene N.V. along with its affiliates, operates globally with a primary focus on rare diseases. The company excels at converting diverse real-world data—spanning clinical, genetic, and other sourc…
what is centogene n.v. · cntg stock overview · centogene n.v. company profile · who is centogene n.v. ceo · cntg NASDAQ · centogene n.v. headquarters · centogene n.v. business segments
About Stock Overview & Key Data
Centogene N.V. (CNTG) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Nov 7, 2019. As of the latest trading session, CNTG stock price is $0.33, with a market capitalization of $9.4M. The stock has returned +150.00% over the past 12 months and +150.00% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Centogene N.V. stock is Buy, with an average 12-month price target of $2.50. In fiscal year 2023, Centogene N.V. reported revenue of $48.5M and net income of -$35.5M. For detailed data — including Centogene N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Centogene N.V. (CNTG) stock price is $0.33. The stock is traded on NASDAQ under the ticker symbol CNTG. The 52-week range is $0.33 – $0.43.